
Julio Chavez, MD, Moffitt Cancer Center
Advertisement
Articles by Julio Chavez, MD, Moffitt Cancer Center
Advertisement
Latest Updated Articles
SADAL Trial OverviewPublished: July 17th 2020 | Updated:
CAR T-Cell Therapy Clinical TrialsPublished: July 17th 2020 | Updated:
DLBCL Risk Assessment and Genetic SignaturesPublished: July 17th 2020 | Updated:
CAR T in Transplant-Eligible and Transplant-Ineligible DLBCLPublished: September 22nd 2020 | Updated:
Therapy Initiation Prior to Cytogenetic Testing ResultsPublished: July 17th 2020 | Updated:
CAR T Cell Therapy in Relapsed/Refractory DLBCLPublished: July 17th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
3
Dr Braunstein on the FDA Approval of Subcutaneous Daratumumab With VRd For Newly Diagnosed Multiple Myeloma
4
Meta-Analysis Characterizes Nivolumab/Ipilimumab Hyperprogression in Renal Medullary Carcinoma
5




















